Title:
Development of grapevine leafroll-associated virus 3 (GLRaV-3) vaccine
Agreement Value:
$34,800.00
Agreement Date:
Jun 1, 2021 - Apr 30, 2022
Description:
The attenuated grapevine leafroll-associated virus 3 will be developed by mutagenesis and tested for protection of GLRaV-3 free tissue culture against the infection of wild-type GLRaV-3 in the field.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP’s Youth Employment Program is to assist in increasing the supply of highly qualified people, promoting the benefits of advanced studies, demonstrating federal leadership by investing in the skills required to meet the needs of the knowledge economy and facilitating the transition of highly skilled young people to a rapidly changing labour market.
Location:
London, Ontario, CA N5V 3P5
Reference Number:
172-2021-2022-Q2-973465
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
101209419
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 47 days. The total amended value is 4,800 dollars.
Amendment Date
Oct 25, 2021
Recipient's Legal Name:
A & L Laboratories Canada Inc.
Federal Riding Name:
London--Fanshawe
Federal Riding Number:
35051
Program:
Industrial Research Assistance Program – Youth Employment Program
Program Purpose:
The purpose of IRAP’s Youth Employment Program is to assist in increasing the supply of highly qualified people, promoting the benefits of advanced studies, demonstrating federal leadership by investing in the skills required to meet the needs of the knowledge economy and facilitating the transition of highly skilled young people to a rapidly changing labour market.
Coverage:
IRAP Youth Employment Program projects stimulate wealth creation for Canada through technological innovation.